Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05918887 · ClinicalTrials.gov registry record · NA
Feasibility and Acceptability of Switching to E-cigarettes Among Cigarette Smokers Engaged in SUD Treatment
A NA study of Tobacco Dependence Caused by Cigarettes, sponsored by University of Nevada, Reno.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT05918887: Completed NA study of Tobacco Dependence Caused by Cigarettes, sponsored by University of Nevada, Reno.
NCT05918887 is a NA study of Tobacco Dependence Caused by Cigarettes that has completed, run by University of Nevada, Reno. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05918887, a NA study of Tobacco Dependence Caused by Cigarettes, has completed, sponsored by University of Nevada, Reno.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the proposed study is to examine the feasibility of integrating a smoking harm reduction program featuring provision of e-cigarettes and tailored instructions to switch into an existing substance use disorder treatment program. This longitudinal study includes three weeks of micro-surveys delivered via text messages to evaluate the intervention's feasibility and acceptability, gather initial effectiveness data, and understand participants' lived experience of smoking and vaping while engaged in substance use disorder treatment.
Primary Outcome
Change in average cigarette consumption per day as a function of daily e-cigarette use
Conditions Studied
Interventions
- DEVICE NJOY ACE commercial e-cigarette
Study Locations (1)
Nevada
- University of Nevada, Reno - Reno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2024-06-18 |
| Est. Completion | 2024-09-13 |
| Phase | NA |
What the finished NCT05918887 record still lists
NCT05918887 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Tobacco Dependence Caused by Cigarettes appearing as the primary indexed condition, and to 1 intervention - of which NJOY ACE commercial e-cigarette is the first listed.
NCT05918887 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT05918887 about?
NCT05918887 is a clinical study titled "Feasibility and Acceptability of Switching to E-cigarettes Among Cigarette Smokers Engaged in SUD Treatment". The purpose of the proposed study is to examine the feasibility of integrating a smoking harm reduction program featuring provision of e-cigarettes and tailored instructions to switch into an existing substance use disorder treatment program. This longitudinal study includes three weeks of micro-sur...
What is the current status of trial NCT05918887?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2024-06-18. Estimated completion is 2024-09-13.
What conditions does trial NCT05918887 study?
This clinical trial studies the following conditions: Tobacco Dependence Caused by Cigarettes.
What interventions are being tested in trial NCT05918887?
The interventions under investigation include: NJOY ACE commercial e-cigarette (DEVICE).
Who is sponsoring clinical trial NCT05918887?
This trial is sponsored by University of Nevada, Reno, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05918887 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Dependence Caused by Cigarettes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05918887's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI